Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Market capitalisation
$154.33M
2,874,013 shares Covers every share class this company has on file.
Insiders on file
2
people who have filed Form 3, 4 or 5 naming this issuer
Value of insider-held stock
$10.45M
from the holdings reported on Forms 3/4/5; this figure has no separate as-of date on file
Insider-held share of market cap
6.77%
insider-held value divided by market capitalisation

What SPRUCE BIOSCIENCES, INC. reports

Revenue and net income below are for fiscal period FY2025, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.

Revenue
$0
FY2025 annual revenue, from this company’s own annual XBRL filings to the SEC
Net income
-$38.97M
FY2025 a loss for the period, from this company’s own annual XBRL filings to the SEC
Employees
22
Yahoo Finance
Where the employee count comes from

Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.

Insiders at SPRUCE BIOSCIENCES, INC.

Shares is what each person last reported holding here.

Everyone below has filed at least one insider report against this company.

Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.

Rows are grouped by the role each person reports.

The role comes from the relationship boxes a person ticks on their own insider filings — officer, director, ten per cent owner — not from anything we infer. Somebody who is both an officer and a director appears once, in the combined group, so the row count still matches the figure at the top of this page. Where no filing states a role we say so instead of guessing one.

People who file insider reports against SPRUCE BIOSCIENCES, INC..
Insider Reported role Shares Value Last action
Officers 1
Ralph William Charlton III Other Executive 161,339 $9.35M M Option exercise or conversion Dec 16, 2024 position reported
Officers who also sit on the board 1
Javier B Szwarcberg CEO 19,004 $1.10M A Grant or award Jun 30, 2026 position reported

Recent insider transactions

Of the 24 rows we hold, 0 are open-market purchases and 0 open-market sales.

The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.

A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.

Insider transactions disclosed to the SEC for SPRUCE BIOSCIENCES, INC., newest first, each with the filing behind it.
Date Insider Transaction Shares Price Value Filing
Jun 30, 2026 Javier B Szwarcberg A Grant or award 266 $4.53 $1.2K SEC filing ↗
Dec 31, 2025 Javier B Szwarcberg A Grant or award 4,690 $4.53 $21.2K SEC filing ↗
Dec 15, 2025 Javier B Szwarcberg M Option exercise or conversion 1,196 $0.00 $0 SEC filing ↗
Dec 15, 2025 Javier B Szwarcberg M Option exercise or conversion 1,480 $0.00 $0 SEC filing ↗
Dec 15, 2025 Javier B Szwarcberg F Shares withheld for taxes 608 $80.67 $49.0K SEC filing ↗
Dec 15, 2025 Javier B Szwarcberg F Shares withheld for taxes 752 $80.67 $60.7K SEC filing ↗
Dec 11, 2025 Javier B Szwarcberg M Option exercise or conversion 4,950 $0.00 $0 SEC filing ↗
Dec 11, 2025 Javier B Szwarcberg F Shares withheld for taxes 2,194 $88.41 $194.0K SEC filing ↗
Dec 10, 2025 Javier B Szwarcberg M Option exercise or conversion 1,196 $0.00 $0 SEC filing ↗
Dec 10, 2025 Javier B Szwarcberg F Shares withheld for taxes 428 $85.67 $36.7K SEC filing ↗
Oct 20, 2025 Javier B Szwarcberg F Shares withheld for taxes 1,539 $148.16 $228.0K SEC filing ↗
Oct 20, 2025 Javier B Szwarcberg M Option exercise or conversion 4,784 $0.00 $0 SEC filing ↗
Dec 16, 2024 Javier B Szwarcberg M Option exercise or conversion 89,700 $0.00 $0 SEC filing ↗
Dec 16, 2024 Javier B Szwarcberg F Shares withheld for taxes 32,005 $0.39 $12.5K SEC filing ↗
Dec 16, 2024 Javier B Szwarcberg M Option exercise or conversion 111,000 $0.00 $0 SEC filing ↗
Dec 16, 2024 Javier B Szwarcberg F Shares withheld for taxes 39,605 $0.39 $15.4K SEC filing ↗
Dec 16, 2024 Ralph William Charlton III M Option exercise or conversion 26,600 $0.00 $0 SEC filing ↗
Dec 16, 2024 Ralph William Charlton III M Option exercise or conversion 31,750 $0.00 $0 SEC filing ↗
Dec 16, 2024 Ralph William Charlton III F Shares withheld for taxes 9,491 $0.39 $3.7K SEC filing ↗
Dec 16, 2024 Ralph William Charlton III F Shares withheld for taxes 11,329 $0.39 $4.4K SEC filing ↗
Dec 10, 2024 Javier B Szwarcberg F Shares withheld for taxes 128,020 $0.54 $69.1K SEC filing ↗
Dec 10, 2024 Javier B Szwarcberg M Option exercise or conversion 358,800 $0.00 $0 SEC filing ↗
Dec 10, 2024 Ralph William Charlton III M Option exercise or conversion 106,400 $0.00 $0 SEC filing ↗
Dec 10, 2024 Ralph William Charlton III F Shares withheld for taxes 37,964 $0.54 $20.5K SEC filing ↗

From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.

What a Form 4 is

The report an officer, director or large shareholder must file after trading their own company’s stock.

Corporate ownership links — 1 filer holds a position

Who owns SPRUCE BIOSCIENCES, INC.

Each row is one filer naming this company.

Funds, trusts and other companies file the same ownership forms that executives do. Everything below is taken from those filings, with the position exactly as the filing states it.

Do not add these figures together. 1 of the positions below was reported on a filing shared by several filers at once.

Why the same shares appear twice

On a joint filing every named filer is listed against the whole position, so the same block of stock appears under each name. Those rows are marked joint.

Filers holding a position in SPRUCE BIOSCIENCES, INC.

Funds, trusts and companies that disclose an ownership position in SPRUCE BIOSCIENCES, INC..
Owner Reported role Shares Filed
Parkman Healthcare Partners LLC TenPercentOwner 1,050 joint

See the full ownership map — every entity that files as an owner of a US public company.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Sources and technical notes

Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.

Share count: cover page of the latest filing (dei:EntityCommonStockSharesOutstanding), taken from SPRUCE BIOSCIENCES, INC.’s own filings and multiplied by our closing price. Full method.

What that share count means

the share count the company itself prints on the cover of its most recent filing, as of the date it signed that filing.

We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from SPRUCE BIOSCIENCES, INC.’s own SEC filings multiplied by the closing price we hold for the same stock.